No phaseNot yet recruiting
Outpatient Pramlintide Study
An Outpatient Crossover Study to Evaluate Insulin and Pramlintide Versus Insulin Alone Delivery Strategy
- Sponsor
- Oregon Health and Science University (Academic or other)
- Enrollment
- 26 planned
- Conditions
- Type 1 Diabetes
- Interventions
- Single-hormone automated insulin delivery system; Dual-hormone automated insulin and pramlintide delivery system
- Ages
- adults, older adults
- Registry
- NCT07914621
Full record on ClinicalTrials.gov
From the registry
The primary purpose of this study is to compare the performance of a dual-hormone automated insulin delivery (AID) system that delivers both insulin and pramlintide with an AID that only delivers insulin. Our hypothesis is that people using the dual-hormone AID will have a significantly increased percent time in range (70-180 mg/dL) compared with when they use a single-hormone insulin-only AID. Both systems are designed to automatically dose meal insulin if the participant forgets to enter their meal insulin at the time of their meals.
Primary outcomes
- Percent of time with sensed glucose between 70-180 mg/dl during the daytime
History
Primary completion expected
Last registry update
Registered
Started